OXOS MEDICAL INC

OXOS MEDICAL INC specializes in the design, development, and manufacturing of advanced medical devices and diagnostic instrumentation, leveraging expertise in precision engineering, embedded systems, and biocompatible materials. The company’s technical capabilities center on FDA-regulated product development, including signal processing for physiological monitoring, low-power medical-grade electronics, and compliance with IEC 60601 and ISO 13485 standards. Their work involves integrating sensors, microcontrollers, and real-time data acquisition systems into clinical-grade hardware, with a focus on reliability, electromagnetic compatibility, and user-centered human factors design. Differentiators include rapid prototyping of custom diagnostic platforms and adherence to strict quality management systems required for Class II medical devices. Award history is not available to infer specific agency engagements or project types. Consequently, no patterns of relationship with federal departments or procurement offices can be confirmed. The primary NAICS code 334510 indicates core activity in the manufacturing of electro-medical and electro-therapeutic apparatus, which in practice means the development of patient monitoring systems, diagnostic sensors, and therapeutic devices intended for hospital, clinic, or home healthcare environments. The company positions itself within the medical device supply chain as a niche innovator focused on hardware-intensive solutions requiring rigorous regulatory validation and clinical validation pathways. OXOS MEDICAL INC is structured as a small business under the 2L entity classification and is headquartered in Atlanta, Georgia. The firm holds no government certifications such as 8(a), HUBZone, or WOSB. Its geographic footprint is limited to its primary operational base, with no public indication of multiple facilities or federal contract performance sites beyond Georgia. The company operates as a specialized manufacturer within the biomedical engineering sector, serving regulated healthcare markets through proprietary device development.